ACUITY PHARMACEUTICALS
Acuity Pharmaceuticals is a pharmaceutical company that is focused on the treatment and prevention of ophthalmic diseases. It develops treatments for age-related macular degeneration and diabetic retinopathy. The company offers Cand5, a clinical compound that is able to shut down vascular endothelial growth factor. Acuity Pharmaceuticals was acquired by OPKO Health in June 2011. Acuity Pharmaceuticals was founded in 2007 and is based in Philadelphia, Pennsylvania.
ACUITY PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2002-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.acuitypharma.com
Total Employee:
501+
Status:
Closed
Contact:
3055754140
Email Addresses:
[email protected]
Total Funding:
19 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator
Similar Organizations
AlliancePharma Inc
AlliancePharma is a leading solution and service provider to the pharmaceutical market.
Botanix Pharmaceuticals
Botanix Pharmaceuticals is a pharmaceutical company that focuses on the treatment of skin diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Cosette Pharmaceuticals
Cosette Pharmaceuticals is a generic pharmaceutical company that specializes in the areas of dermatology and allergy.
Eyecare Partners
A growing family of independent primary eyecare practices and a portfolio company of FFL Partners
Plumb Pharmaceuticals
Plumb Pharmaceuticals provides health-care cost reduction solutions for people suffered from chronic diseases.
PROSION
PROSION is a pharmaceutical and drug discovery start-up company.
Somar
Pharmaceutical company in the health sector
Visant Medical
Visant Medical develops a patented and proprietary approach to dry eye treatment.
Investors List
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Acuity Pharmaceuticals
BioAdvance
BioAdvance investment in Series B - Acuity Pharmaceuticals
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Series B - Acuity Pharmaceuticals
Diamond Capital Company
Diamond Capital Company investment in Series B - Acuity Pharmaceuticals
Psilos Group
Psilos Group investment in Series B - Acuity Pharmaceuticals
BioAdvance
BioAdvance investment in Venture Round - Acuity Pharmaceuticals
Official Site Inspections
http://www.acuitypharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acuity Pharmaceuticals"
Acuity Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected] Phone Number 3055754140 Acuity Pharmaceuticals is a pharmaceutical company that is focused on the treatment and prevention of ophthalmic diseases.See details»
Acuity Pharmaceuticals - Overview, News & Similar companies
Who is Acuity Pharmaceuticals. Founded in 2002, Acuity Pharmaceuticals is a product- focused ophthalmic pharmaceutical company applying its proprietary technology to the treatmen t and …See details»
Acuity Pharmaceuticals Company Profile | Management and
Www.acuitypharma.com Acuity Pharmaceuticals Profile and History Founded in 2002, Acuity Pharmaceuticals is a product- focused ophthalmic pharmaceutical company applying its …See details»
Acuity Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...
Jul 29, 2024 Explore Acuity Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 news, and 2 literature.See details»
Acuity Pharmaceuticals | Company | Mindmaps
Acuity Pharmaceuticals is a pharmaceutical company that is focused on the treatment and prevention of ophthalmic diseases. It develops treatments for age-related macular …See details»
Acuity Pharmaceuticals - Products, Competitors, Financials, …
A portion of this line ofcredit has already been committed to help fund the transition to the new organization.Proceeds from this line of credit, along with the approximately $16 million of cash …See details»
Acuity Pharmaceuticals Inc - Company Profile and News
Company profile page for Acuity Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Acuity Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Acuity Pharmaceuticals is a company that provides Health care, Vascular endothelial growth factor, Diabetic retinopathy and more. Acuity Pharmaceuticals is headquartered in United …See details»
Acuity Pharmaceuticals - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; US-20070149471-A1: Gene expression inhibition using small interfering rnas which are specific for the vascular …See details»
Acuity Pharmaceuticals, Inc.:Company Profile & Technical Research ...
Acuity Pharmaceuticals, Inc. is a company that provides Vascular endothelial growth factor, Diabetic retinopathy, Macular degeneration and more.See details»
Acuity Pharmaceuticals, Inc - VentureRadar
Acuity Pharmaceuticals, Inc VentureRadar profile. Find out more about Acuity Pharmaceuticals, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Acuity Pharmaceuticals - F6S
Acuity Pharmaceuticals - Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.See details»
ZaBeCor Pharmaceutical Co. Licenses Its Anti-Inflammatory
PHILADELPHIA, April 28 /PRNewswire/ -- ZaBeCor Pharmaceutical Co., a privately-held company focused on the development and commercialization of patented drug technology …See details»
Acuity Pharmaceuticals Completes Patient Enrollment In Phase
Feb 2, 2006 The World Health Organization estimates that 15 million Americans have diabetes and more than 150 million people worldwide have the disease. After 20 years, nearly all …See details»
Acuity Pharmaceuticals Continues Pipeline Expansion By
PHILADELPHIA, April 20 /PRNewswire/ -- Acuity Pharmaceuticals, Inc., a clinical stage, product-focused ophthalmic pharmaceutical company, today announced that it has in-licensed …See details»
COMPANY PROFILE - Acuity Brands
FORWARD LOOKING STATEMENT This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995.See details»
In Landmark Step, Acuity Is First Firm to Begin RNAi-based Drug …
Nov 12, 2004 Acuity Pharmaceuticals said on Nov. 9 that the first patients in a phase I trial of the company’s investigational siRNA-based age-related macular degeneration treatment, Cand5, …See details»
Pharma Acuity
PharmaAcuity is transforming how biotech and pharma companies like yours find and engage the right opinion leader – whether in the scientific, clinical, regulatory, or advocacy arena.See details»
Acuity Pharmaceuticals Reports Positive Initial Phase II ... - BioSpace
Jun 1, 2006 PHILADELPHIA and BALTIMORE, June 1 /PRNewswire/ -- Acuity Pharmaceuticals, an ophthalmic pharmaceutical company, today announced that its lead clinical compound …See details»
Acuity Pharmaceuticals Reports Positive Phase II Results For
Sep 11, 2006 PHILADELPHIA and CANNES, France, Sept. 11 /PRNewswire/ -- Acuity Pharmaceuticals, a clinical stage ophthalmic pharmaceutical company, today announced …See details»